Showing results (351-360 of 374) with videos related to
Sort By:
Pageof 38
Allergy|December 7, 2007
Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergyG Hens, B M Vanaudenaerde, D M A Bullens, et al.Thorax|March 26, 2005
Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004M Decramer, R Gosselink, M Rutten-Van Mölken, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Consensus: the follow-up of the treated patientM Saunders, J P Sculier, D Ball, et al.Respiratory Medicine|February 7, 2012
Determinants of physical activity in daily life in candidates for lung transplantationD Langer, M A Cebrià i Iranzo, C Burtin, et al.The European Respiratory Journal|June 19, 2001
The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial CommitteeM Decramer, P N Dekhuijzen, T Troosters, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.British Journal of Cancer|October 12, 2000
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, M Paesmans, et al.European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Critical factors for patient managementV Ninane, C Le Pechoux, W Curran, et al.Pageof 38